Page last updated: 2024-08-21

oxazoles and transforming growth factor beta

oxazoles has been researched along with transforming growth factor beta in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fontana, A; Groscurth, P; Malipiero, U; Weller, M1
Khwaja, S; Miao, L; Nanji, AA; Rahemtulla, A; Tahan, SR; Zhao, S1
Dai, C; Liu, Y; Yang, J1
Chen, XL; Cheng, T; Chu, TG; Gao, WY; Jiang, LF; Li, XY; Li, ZJ; Pan, H; Yang, JQ; Yi, CG; Yu, Q; Zhang, GY; Zheng, MH; Zhou, FY1
Haga, S; Hamano, T; Hirai, T; Ishizaka, Y; Mimori, A; Tsuchiya, H1

Other Studies

5 other study(ies) available for oxazoles and transforming growth factor beta

ArticleYear
T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A.
    Experimental cell research, 1995, Volume: 221, Issue:2

    Topics: Animals; Apoptosis; Cell Division; Cell Line; Cell Membrane; DNA Damage; Endoplasmic Reticulum, Rough; Enzyme Inhibitors; Ethers, Cyclic; Gene Expression Regulation; Interleukin-2; Marine Toxins; Mice; Nucleosomes; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 1; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma Protein; RNA, Messenger; T-Lymphocytes; Transforming Growth Factor beta

1995
Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat.
    Gastroenterology, 1997, Volume: 112, Issue:1

    Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Fatty Liver, Alcoholic; Liver Diseases, Alcoholic; Male; Oxazoles; Rats; Rats, Wistar; Thromboxane A2; Thromboxane B2; Transforming Growth Factor alpha; Transforming Growth Factor beta

1997
Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling.
    The Journal of biological chemistry, 2003, Apr-04, Volume: 278, Issue:14

    Topics: Caspase 3; Caspase 9; Caspases; Cell Death; Cells, Cultured; DNA-Binding Proteins; Enzyme Inhibitors; Enzyme Precursors; Epithelial Cells; Humans; Kidney Tubules, Proximal; Mitogen-Activated Protein Kinases; Oxazoles; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Smad2 Protein; Smad7 Protein; Staurosporine; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1

2003
Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro.
    Archives of dermatological research, 2009, Volume: 301, Issue:7

    Topics: Cell Growth Processes; Cells, Cultured; Cicatrix, Hypertrophic; Connective Tissue; Connective Tissue Growth Factor; Dose-Response Relationship, Immunologic; Extracellular Matrix; Fibroblasts; Humans; Oxazoles; PPAR gamma; Prostaglandin D2; Transcriptional Activation; Transforming Growth Factor beta; Tyrosine

2009
A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression.
    Experimental lung research, 2015, Volume: 41, Issue:1

    Topics: Angiotensin-Converting Enzyme 2; Animals; Caveolin 1; Drug Evaluation, Preclinical; Enzyme Activation; Feedback, Physiological; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Janus Kinases; Male; Monocrotaline; Oxazoles; Peptidyl-Dipeptidase A; Pyrimidines; Rats, Sprague-Dawley; STAT Transcription Factors; Transforming Growth Factor beta

2015